Alvaro San-Juan-Rodriguez

Fellow in Pharmacoeconomics and Outcomes Research @PittPharmacy and @PittCP3. @UNAV alumnus. MSc Candidate @PittPubHealth

[Alvaro San-Juan-Rodriguez @asjrodriguez]

Check out our latest article on drug pricing just published in @JAMA_current In this study we evaluate 2007-2018 trends in list prices, net prices and manufacturer discounts for 602 brand drugs!

[Pitt General Internal Medicine @PittGIM]

Despite growing manufacturer discounts, net prices of self-administered injectable tumor necrosis factor inhibitors still increased at a mean annual rate of 9.6% in 2007-2019. New @PittCP3 @amcporg study with PittGIM's @CBGood23 & @walidgellad. @ihdezdelso https://t.co/SwztVFa5gZ

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

New year, new publication! CP3's @asjrodriguez, @CBGood23, @walidgellad, @ihdezdelso with @pittpharmacy's Vincent Piro examined price trends of injectable TNF factors and found net prices of adalimumab tripled.
https://t.co/QNtWALFqWm
@PittGIM @vaequity @PittHealthSci

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

New paper in @JournalGIM from our top drug price research team of @ihdezdelso, @asjrodriguez, @CBGood23, & @walidgellad determined that most #Medicare Part D discounts originate from a few therapeutic classes of drugs.
https://t.co/aAuqt7RZHQ

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

Are you an #ARM2020 attendee? Check out our faculty and postdocs' posters at this afternoon's session!

[JAMA Oncology @JAMAOnc]

Cohort study finds biologics with biosimilar competition experienced marked reductions in net prices and leveling off of list prices increases https://t.co/XAKXMBXw9B @asjrodriguez @ihdezdelso

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

“It comes back to financial incentives,” CP3's @ihdezdelso said during the @US_FDA / @FTC session on #biosimilars last week. Read more on @politico's coverage of the event.
https://t.co/xxtKthtZ9q

[Lawrence W. Abrams @larrywabrams]

@Varro_Analytics @peterbachmd @PredatorDiaries @LillyPad Best publicly available charts on #biosimilars gross to net prices of reference drug upon entry of biosimilars is recent JAMA article by great team at @PittPubHealth https://t.co/E3CBScCOY7

[Dr. Ali Khan @DrAliSKhan]

Recent 11-yr period on branded pharmaceutical products in the US: list prices increased by 159%, net prices increased by 60%, discounts offset 62% of increases in list prices for drugs. So you paid 3.5x inflation for drug & rest in insurance & taxes
https://t.co/bPWO14z30G

[Scott Stapf @stapf]

The price of brand-name prescription drugs went up by 60% between 2007 and 2018, after accounting for rebates and discounts, according to a new study in JAMA. https://t.co/6ZzLRL2Qzv

[FDB (First Databank Inc.) @FDB_US]

Thank you for your excellent, thorough research on drug prices, as always. We are honored to referenced as a source for your work. @walidgellad @CBgood23 @asjrodriguez

[JAMA @JAMA_current]

@PittCP3 @walidgellad @AlJazeera @ihdezdelso Here's a link to the study, free for a limited time: https://t.co/lVGw0GvQYO

[pharmalot @pharmalot]

Drug prices rose three times faster than inflation over the past decade, despite discounts.. https://t.co/LNbr1ZH4kE #pharma #drugprices #rebates $MRK

[Matthew Herper @matthewherper]

No heroes here. Drug prices rose a lot. The supply chain took half the money. https://t.co/zvkLwqAdpI

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

It's Super Tuesday here at CP3! We are thrilled to have THREE papers in the new issue of @JAMA_current highlighting our expertise in drug pricing and research funding. @PittGIM @pittwirehealth @pittpharmacy @PittPubHealth @vaequity

1/4

[Center for Pharmaceutical Policy and Prescribing @PittCP3]

@JAMA_current @PittGIM @pittwirehealth @pittpharmacy @PittPubHealth @vaequity @walidgellad Next, top drug pricing team @ihdezdelso. @asjrodriguez, @CBGood23, and @walidgellad describe the effects manufacturer discounts have had on drug prices in the US. Net prices still saw substantial increases.
https://t.co/nuYFFA9jgp

3/4